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Executive Summary 
Introduction of the Problem 
 Millions of Americans are affected by chronic low back pain and migraines. According to 
the Centers for Disease Control and Prevention (CDC), chronic low back pain affects over 50 
million adults in the United States, while migraines affect more than 39 million 
Americans.  (CDC, 2018; Migraine Research Foundation, 2019). In the U.S., the annual cost of 
low back pain and migraines is greater than $150 billion, mainly due to lost productivity (Legget 
et al., 2014; National Headache Foundation, 2019). The recent opioid epidemic has created more 
demand for alternative pain management remedies. In 2017 alone, nearly 50,000 people died due 
to opioid overdose (CDC, 2019).   
For many patients, the terminology of healthcare is difficult to understand. The limited 
amount of time spent with practitioners is not adequate to facilitate proper education. On the 
other hand, some practitioners may be unaware of the non-opioid therapies that are available. To 
address these problems, we collaborated with a critical access hospital in rural Illinois to create 
and distribute educational materials in the form of pamphlets to patients regarding interventional 
techniques for the management of chronic back pain and migraine headaches. Additionally, a 
presentation on available alternative interventions and their benefits was given to practitioners 
who will potentially refer patients to the pain clinic. 
Literature Review 
Rhizotomy, another term for Radiofrequency ablation (RFA), is a minimally invasive 
procedure that uses radiofrequency waves delivered through a needle to interrupt pain from 
being sent to the brain (Lockeretz,2019). Low back pain affects up to 90% of the population 
today, making it the most common type of pain in modern times (Rimalpudi & Kumar, 2017). 
Lower back pain can be caused by injuries to several structures, including lumbar vertebral 
bodies, intervertebral discs, facet joints, spinal nerves, the surrounding muscles, and ligaments. 
Sacroiliac joint (SIJ) dysfunction affects up to 30%, while lumbar facet joints affect up 40% of 
people with back pain (Rimalpudi & Kumar, 2017).  About 10 percent of these patients’ back 
pain becomes chronic (Choi et al., 2016; Rimalpudi & Kumar, 2017).  
The target structures of RFA include the lateral branches of the sacral rami, the dorsal 
ramus of L5, and the ligamentous structures overlying the joint (Choi et al., 2016). To perform 
successful RFA, the nerve that is responsible for the pain pathway must be identified. As such, it 
is imperative that proper differential diagnosis of the exact source of the back pain is conducted 
for more precise identification of the pain generator nerve (Ibrahim et al., 2019).  Utilization of 
peripheral nerve blocks and intra-articular steroid shots is not only useful in short term pain relief 
but also as a good predictor of RFA success (Choi et al., 2016). To ensure effective RFA, it is 
recommended to denervate multiple potential sources of pain, including the intra-articular joint, 
lateral sacral branches of S1–3, and the L5 dorsal ramus (Choi et al., 2016).   
RFA intervention has been attributed to a significant long-term reduction in chronic low 
back pain (Ibrahim et al., 2019; Rimalpudi & Kumar, 2017). Following three-month interval 
follow-ups, patients who underwent RFA for low back pain continued to report a reduction 
in the severity of their pain for up to two years (Ibrahim et al., 2019). Further, patients who 
received RFA were able to distinguish secondary pain that was previously masked by primary 
back pain (Rimalpudi & Kumar, 2017). It is important to note that pain relief from RFA may be 
temporary, necessitating additional treatments within six months to a year (Jeong et al., 2014). 
This phenomenon is attributed to the ability of the medial branch of the dorsal ramus to 
regenerate after RFA denervation (Jeong et al., 2014).   
Migraine headaches affect roughly 11 to 15 percent of the world’s population (Castaldo 
et al., 2019; Binfalah et al., 2018). It is a debilitating condition that can last for days. There are a 
variety of treatments available to patients, such as nonsteroidal anti-inflammatory drugs, 
acetaminophen, analgesics, triptans, and antiemetics. Many of these medications carry unwanted 
side effects, and their efficacy is less than optimal (Binfalah et al., 2018). For those reasons, 
alternative remedies such as greater occipital nerve blocks, sphenopalatine ganglion nerve 
blocks, and Botox injections are used in the treatment of migraine headaches.  
Greater occipital nerve blocks are an opioid-sparing, nonpharmacological method for the 
treatment of migraine headaches. The greater occipital nerve originates from the C2 dorsal root 
and is the primary sensory nerve in the occipital zone (Chen et al., 2018; Aledo-Serrano et al., 
2017). Administration of local anesthetics and corticosteroids, such as 2ml of 0.5% bupivacaine, 
1ml of 2% lidocaine, and 0.5ml (20mg) methylprednisolone are administered through a needle 
introduced into the inferolateral facet of the occipital protuberance (Allen et al., 2018). With 
greater occipital nerve blocks, afferent input to the trigeminal nucleus caudalis is decreased 
(Allen et al., 2018). This reduces neuronal hyperexcitability in the second-order neuron through 
central pain modulation (Allen et al., 2018). Two double-blind, randomized, placebo-controlled 
clinical trials by Cuadrado et al. (2017) and Kashipazha et al. (2014) showed migraine 
improvements with greater occipital nerve blocks. The average pain scores decreased with 
treatment and the number of headache days went down as well (Kashipazha et al., 2014).  
Sphenopalatine blocks target the sphenopalatine ganglion, which is located within the 
pterygopalatine fossa (Cady et al., 2015). It is posterior to the middle turbinate and is the largest 
extracranial collection of neurons (Cady et al., 2015; Mehta et al., 2019). The trigeminal nerve 
provides innervation through the maxillary division to the sphenopalatine ganglion (Cady et al., 
2015; Robbins et al., 2016). Transnasal and suprazygomatic are two approaches to anesthetizing 
these nerves. The easiest approach is transnasal with cotton pledgets or cotton swabs soaked with 
local anesthetic. The patient is placed in the supine position, and the cotton swabs are advanced 
roughly 6cm into the nares for 5 minutes (Grosh & Ayubcha, 2018). This is usually repeated 
three times each visit, and patients can have the procedure done frequently, even twice a week. 
(Grosh & Ayubcha, 2018; Charlestion et al., 2015). A double-blind, placebo-controlled study by 
Cady et al. (2015) used 0.3ml of 0.5% bupivacaine and saline as a placebo. Twelve series of 
treatments were performed over six weeks on patients. The study by Cady et al. (2015) had 
baseline pain scores for the treatment group and control group that were nearly equal before the 
procedure. By the 12th week, pain scores for the treatment group were lower than baseline and 
lower than the control group as well (Cady et al., 2015). The suprazygomatic technique is 
considered to be more accurate than the trans nasal technique (Mehta et al., 2019). However, it is 
more challenging and carries more risk (Mehta et al., 2019). Caution when performing these 
techniques is essential to avoid palsies of the abducens and facial nerves (Mehta et al., 2019). A 
retrospective study by Mehta et al. (2019) evaluated the effectiveness of the suprazygomatic 
sphenopalatine block. In the study, results showed a statistically significant decrease in inpatient 
pain scores, with a decrease in the median pain score from eight to two on the Likert pain scale 
(Mehta et al., 2019).  
Onabotulinumtoxina, also known as Botox, is a neurotoxin that inhibits nerve impulses 
by blocking presynaptic acetylcholine release (Ninan & Sayyed Farhan, 2009; Lyseng-
Williamson & Frampton, 2012). This results in decreased muscle contractions related to the 
blockade of overactive nerve impulses (Lyseng-Williamson & Frampton, 2012). Various studies 
have demonstrated the effectiveness of onabotulinumtoxina in reducing pain associated with 
migraine headaches such as Aurora et al. (2010). It is theorized that the inhibition of nociceptive 
mediators released from afferent neurons is responsible for decreasing pain (Blumenfeld et al., 
2017). Onabotulinumtoxina is administered in 7 different muscle groups (Blumenfeld et al., 
2017). These seven muscles include the corrugator, frontalis, temporalis, occipitalis, cervical 
paraspinal, and trapezius muscle (Blumenfeld et al., 2017). A large double-blind, randomized 
placebo-controlled study by (Aurora et al., 2010) suggests injecting 155 units of 
onabotulinumtoxina in 31 sites across these seven muscle groups. Results from Aurora et al. 
(2010), Ninan & Sayyed Farhan (2009) showed that onabotulinumtoxina for migraine treatment 
is effective at reducing pain and the number of headache days.  
Methodology  
The purpose of this project was to educate healthcare providers and patients about 
alternative therapies for migraine headaches and chronic low back pain. Numerous studies such 
as Aurora et al. (2010), Cady et al. (2015), Choi et al. (2016),  Kashipazha et al. (2014), & 
Rimalpudi & Kumar (2017) suggest that these treatments may help alleviate pain while reducing 
the number of opioids that are being prescribed to patients. To curb the rampant opioid addiction 
crisis, it is crucial to offer alternative opioid-sparing therapies.  A presentation was held at a 
critical access hospital in Central Illinois. It outlined the evidence surrounding greater occipital 
nerve blocks, sphenopalatine blocks, and Botox for the treatment of migraine headaches, as well 
as radiofrequency ablation for the treatment of chronic low back pain. Pamphlets related to these 
alternative therapies were distributed to the providers so that they can give them to their patients 
who are considering such treatments. We hope the brochures will enhance patient knowledge 
about the alternatives to opioid medications and help combat the ongoing opioid epidemic crisis. 
The presentation was for healthcare workers only, such as primary care physicians, ER 
Physicians, and nurse practitioners. These healthcare workers are in direct contact with the 
public, which allows them to refer any potential candidates to the pain clinic. Following the end 
of the presentation, a survey was administered to healthcare workers. 
This project is a quality improvement project, and it was deemed exempt by the 
Institutional Review Board (IRB) at Southern Illinois University Edwardsville as a non-research-
based project. It did not involve any interactions with patients or the collection of patient 
information. To minimize potential risks to participants, no personal identifiers were collected 
other than participant title.  
Evaluation 
This project evaluated physicians, CRNAs, and other healthcare workers’ knowledge 
related to alternative therapies for migraine headaches and chronic low back pain available at the 
hospital’s pain clinic. A presentation was delivered to health care providers at a rural critical 
access hospital in the Midwest. Informational pamphlets were distributed following the 
presentation. A post-presentation survey was administered to all providers who were in 
attendance. The survey contained a series of Likert items in addition to open-ended qualitative 
questions. Items were formatted to ascertain knowledge of available treatments at the hospital 
and the overall impression of the education pamphlets. The following three outcomes were set to 
measure the success of the project: 70% of participants are able to identify the opioid sparing 
interventions available at the hospital, participants indicate that they are more likely to refer 
patients to the clinic after the presentation, and participants express satisfaction with the overall 
quality of the educational pamphlets.  
Survey data revealed that 45.5% (n=5) of the participants correctly answered which 
treatments are available at the hospital. We explored the possibility that our presentation may 
have been ineffective at educating the participants about available interventional treatment 
options for chronic pain. Notably, half of the participants that answered incorrectly were not 
referring providers. Furthermore, the nature of the environment during the presentation could 
have hindered the effectiveness of our presentation. It was conducted during lunch hour when 
people were moving around, eating lunch, and socializing. A quieter venue would have allowed 
for a more attentive audience, which may have aided in better information recall. A pre and post-
test design that compares pre- and post-knowledge of available treatment options for chronic 
back pain and migraine headaches might have provided for a more conclusive analysis. 
 Nevertheless, the data from the Likert scale questions were favorable. All questions had 
a mean score at or above 6.27 on a 7.0 scale. Based on the data from the survey, the pamphlets 
were a success and received a mean score of at or greater than 6.3 on a 7.0 scale. Among the 
participants, 90.9% selected that they agree or strongly agree that they are more likely to refer 
patients to the pain clinic. By all accounts, the project proceeded as planned and was free of 
major setbacks.  
Impact on Practice  
The purpose of this project was to educate healthcare providers and patients about 
alternative therapies for migraine headaches and chronic low back pain. The hospital has various 
interventions available such as radiofrequency ablation for chronic back pain and three different 
treatments for migraines. These interventions include greater occipital nerve blocks, 
sphenopalatine ganglion blocks, and Botox. Prior to the implementation of the project, there 
were no educational pamphlets available to distribute to patients regarding interventional 
techniques for migraine headaches and chronic low back pain. It is estimated that nine out of ten 
people have a deficiency in health literacy (Department of Health & Services, 2010). Pamphlets 
are useful in facilitating patient education (Adirim et al., 2012). After discussing treatments with 
providers, pamphlets can be handed out to reinforce the information that was discussed in the 
office. The pictures and diagrams can help facilitate a better understanding of the treatments and 
encourage the patients to ask providers more questions. This in turn, may result in a better-
informed patient population and further enhance patient compliance.  
Results from the survey showed that an overwhelming majority of the participants 
expressed that the pamphlets would help facilitate patient education. The data on provider's 
knowledge of available interventions is likely skewed by the fact that half of the participants that 
answered incorrectly were not providers. While only 45.5% (n=11) of the participants 
successfully identified available opioid sparing interventions available at the pain clinic when 
filtered for physicians and APPs that number increased to 72.7%. Consequently, they indicated 
that they are more likely to refer patients to the pain clinic for such treatments. This is beneficial 
to the community because it may decrease the number of people who are opioid dependent, and 
further reduce the incidence of opioid overdose. Over time, the number of opioid prescriptions at 
the hospital for chronic pain management should be expected to decrease as more patients opt to 
receive opioid-sparing interventions. The pain clinic may see growth due to increased referrals 
from providers and an overall surge in demand from satisfied patients.  
Conclusion  
Evidence-based research indicates that RFA for lower back pain and pain interventions 
for migraine headaches are options for patients whose pain is not adequately controlled by 
conventional therapies such as exercise, opiates, and non-opiate medications. In light of the 
current opioid epidemic, minimally invasive interventions with relatively low risk and high 
efficacy can be expected to become more popular. Proper education for both providers and 
patients can result in a better understanding of such interventions. The results of this project 
suggest that practitioners are more likely to refer patients to the pain clinic and distribute the 
pamphlets to patients following the educational presentation. Ultimately, with the rise in the 
awareness of minimally invasive interventions for chronic back pain and migraines headaches, 
such services will become more accessible to patients.  
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